Mutations within the 5′ region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma

References

• Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 1992; 267: 10709–10715
   PubMed Web of Science ®Google Scholar
• Smith K G, Nossal G J, Tarlinton D M. Fas is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc Natl Acad Sci USA 1995; 92: 11628–11632
   PubMed Web of Science ®Google Scholar
• Martinez-Valdez H, Guret C, de Bouteiller O, Fugier I, Banchereau J, Liu Y J. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, p53 and Bax but not the survival gene bcl-2. J Exp Med 1996; 183: 971–977
   PubMed Web of Science ®Google Scholar
• Landowski T H, Moscinski L, Burke R, Buyuksal I, Painter J S, Goldstein S, et al. CD95 antigen mutations in hematopoietic malignancies. Leuk Lymphoma 2001; 42: 835–846
   PubMed Web of Science ®Google Scholar
• Lee S H, Shin M S, Park W S, Kim S Y, Dong S M, Pi J H, et al. Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder. Cancer Res 1999; 59: 3068–3072
   PubMed Web of Science ®Google Scholar
• Takakuwa T, Dong Z, Takayama H, Matsuzuka F, Nagata S, Aozasa K. Frequent mutations of Fas gene in thyroid lymphoma. Cancer Res 2001; 61: 1382–1385
   PubMed Web of Science ®Google Scholar
• Wohlfart S, Sebinger D, Gruber P, Buch J, Polgar D, Krupitza G, et al. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Am J Pathol 2004; 164: 1081–1089
   PubMed Web of Science ®Google Scholar
• Muschen M, Re D, Jungnickel B, Diehl V, Rajewsky K, Kuppers R. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med 2000; 192: 1833–1840
   PubMed Web of Science ®Google Scholar
• Boldrini L, Faviana P, Gisfredi S, Di Quirico D, Lucchi M, Mussi A, et al. Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer. Int J Oncol 2002; 20: 155–159
   PubMed Web of Science ®Google Scholar
• Gronbaek K, Straten P T, Ralfkiaer E, Ahrenkiel V, Andersen M K, Hansen N E, et al. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 1998; 92: 3018–3024
   PubMed Web of Science ®Google Scholar
• Muschen M, Rajewsky K, Krönke M, Küppers R, et al. The origin of CD95-gene mutations in B-cell lymphoma. Trends Immunol 2002; 23: 75–80
   PubMed Web of Science ®Google Scholar
• Abramson J S, Shipp M A. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving towards a molecularly targeted approach. Blood 2005; 106: 1164–1174
   PubMed Web of Science ®Google Scholar
• Krol A D, le Cessie S, Snijder S, Kluin-Nelemans J C, Kluin P M, Noordijk E M. Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 2003; 14: 131–139
   PubMed Web of Science ®Google Scholar
• Moller M B, Pedersen N T, Christensen B E. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation—a population-based study of 1575 cases. Br J Haematol 2004; 124: 151–159
   PubMed Web of Science ®Google Scholar
• Hans C P, Weisenburger D D, Greiner T C, Gascoyne R D, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275–282
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. World Health Organization Classification of Tumors. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. IARC, Lyon 2001
   Google Scholar
• Stefanoff C G, Hassan R, Gonzalez A C, Andrade L A, Tabak D G, Romano S, et al. Laboratory strategies for efficient handling of paraffin-embedded tissues for molecular detection of clonality in non-Hodgkin lymphomas. Diagn Mol Pathol 2003; 12: 79–87
   PubMed Web of Science ®Google Scholar
• Braggio E, Bonvicino C R, Vargas F R, Ferman S, Eisenberg A LA, Seuanez H N. Identification of three novel RB1 mutations in Brazilian patients with retinoblastoma by exon PCR mediated SSCP analysis. J Clin Pathol 2004; 57: 585–590
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Stein H, Banks P M, Chan J K, Cleary M L, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Alizadeh A A, Eisen M B, Davis R E, Ma C, Lossos I S, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511
   PubMed Web of Science ®Google Scholar
• Pileri S A, Dirnhofer S, Went P, Ascani S, Sabattini E, Marafioti T, et al. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathol 2002; 41: 482–509
   PubMed Web of Science ®Google Scholar
• Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005; 23: 2797–2804
   PubMed Web of Science ®Google Scholar
• Seeberger H, Starostik P, Schwarz S, Knörr C, Kalla J, Ott G, et al. Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT- type lymphoma development. Lab Invest 200; 81: 977–986
   Google Scholar
• Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler O D, Deckert M. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 2004; 103: 1869–1875
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti R S, Kuppers R, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341–346
   PubMed Web of Science ®Google Scholar
• Kramer M H, Hermans J, Wijburg E, Philippo K, Geelen E, van Krieken J H, et al. Clinical relevance of BCL2, BCL6 and MYC rearrangements in diffuse large B cell lymphoma. Blood 1998; 92: 3152–3162
   PubMed Web of Science ®Google Scholar
• Rao P H, Houldsworth J, Dyomina K, Parsa N Z, Cigudosa J C, Louie D C, et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998; 92: 234–240
   PubMed Web of Science ®Google Scholar
• Richardson M E, Chen Q G, Filippa D A, Offit K, Hampton A, Koduru P R, et al. Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. Blood 1987; 70: 444–447
   PubMed Web of Science ®Google Scholar
• Lossos I S, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene. Blood 2000; 96: 635–639
   PubMed Web of Science ®Google Scholar
• Matolcsy A, Casali P, Warnke R A, Knowles D M. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood 1996; 88: 3937–3944
   PubMed Web of Science ®Google Scholar
• Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez P L, et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 91: 2977–2984
   PubMed Web of Science ®Google Scholar
• Do B, Lossos I S, Thorstenson Y, Oefner P J, Levy R. Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma. Leuk Lymphoma 2003; 4: 1317–1323
   Google Scholar
• Shen H M, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998; 280: 1750–1752
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 1998; 95: 11816–11821
   PubMed Web of Science ®Google Scholar
• Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewsky K, et al. Somatic hypermutation in normal and transformed human B cells. Immunol Rev 1998; 162: 261–280
   PubMed Web of Science ®Google Scholar
• Gordon M S, Kanegai C M, Doerr J R, Wall R. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc Natl Acad Sci USA 2003; 100: 4126–4131
   PubMed Web of Science ®Google Scholar